课题基金 / 基金详情

NEW GNRH ANTAGONIST IN TREATMENT OF METASTATIC PROSTATE CANCER

NEW GNRH ANTAGONIST IN TREATMENT OF METASTATIC PROSTATE CANCER
治疗转移性前列腺癌的新型 GNRH 拮抗剂
批准号：
6275415
负责人：
Margaret E Wierman
金额：
$3.14万
依托单位：
UNIVERSITY OF COLORADO DENVER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6275415
关键词：
clinical research gonadotropin releasing factor gonadotropins hormone regulation /control mechanism hormone therapy human subject human therapy evaluation inhibitor /antagonist neoplasm /cancer chemotherapy prostate neoplasms

项目摘要

项目成果

Margaret E Wierman的其他基金

相似基金

相关文献

中文摘要
翻译
这是一种新的促性腺激素释放激素拮抗剂的3中心II/III期试验，用于 前列腺癌患者。这项研究的目的是看看 GnRH激动剂的拮抗剂与先前使用的GnRH激动剂与急性或 慢性促性腺激素反应或急性耀斑反应。
英文摘要
This is a 3 center phase II/III trial of a new gnrh antagonist for use in patients in prostate cancer. The purpose of this study was to see if the antagonist vs prior use of gnrh agonist was associated with an acute or chronic gonadotropin response or acute flare response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma
Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma
Targeting Kinases in Novel Preclinical Models of Adrenocortical Carcinoma
Role of the Sterile20 (Ste20)-like kinase MST4 in Pituitary Tumorigenesis
海外基金